speb/financial-data huggingface dataset:
CARE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -382071000.00
CARE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 70791000.00
CARE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -2914000.00
CARE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 3549000.00
CARE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1357000.00
CARE cash_flow (annual, 2022-12-31) — Change In Working Capital: -722000.00
CARE cash_flow (annual, 2022-12-31) — Changes In Cash: -230930000.00
CARE balance_sheet (annual, 2022-12-31) — Common Stock: 23957000.00
CARE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
CARE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 328627000.00
CARE cash_flow (annual, 2022-12-31) — Common Stock Payments: -42927000.00
CARE cash_flow (annual, 2022-12-31) — Deferred Income Tax: 4251000.00
CARE cash_flow (annual, 2022-12-31) — Deferred Tax: 4251000.00
CARE cash_flow (annual, 2022-12-31) — Depreciation: 6063000.00
CARE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 6063000.00
CARE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 6063000.00
CARE income_statement (annual, 2022-12-31) — Diluted Average Shares: 24595789.00
CARE income_statement (annual, 2022-12-31) — Diluted EPS: 2.03
CARE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 50118000.00
CARE cash_flow (annual, 2022-12-31) — End Cash Position: 46869000.00
CARE cash_flow (annual, 2022-12-31) — Financing Cash Flow: 80350000.00
CARE cash_flow (annual, 2022-12-31) — Free Cash Flow: 64901000.00
CARE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -46000.00
CARE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CARE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -73000.00
CARE income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 46000.00
CARE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -85616000.00
CARE income_statement (annual, 2022-12-31) — General And Administrative Expense: 54414000.00
CARE balance_sheet (annual, 2022-12-31) — Gross PPE: 111138000.00
CARE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CARE cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 5793000.00
CARE income_statement (annual, 2022-12-31) — Insurance And Claims: 2015000.00
CARE income_statement (annual, 2022-12-31) — Interest Expense: 20254000.00
CARE income_statement (annual, 2022-12-31) — Interest Income: 160028000.00
CARE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 19338000.00
CARE balance_sheet (annual, 2022-12-31) — Invested Capital: 509177000.00
CARE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -382071000.00
CARE balance_sheet (annual, 2022-12-31) — Investments And Advances: 836273000.00
CARE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 300550000.00
CARE balance_sheet (annual, 2022-12-31) — Land And Improvements: 19703000.00
CARE balance_sheet (annual, 2022-12-31) — Leases: 1618000.00
CARE balance_sheet (annual, 2022-12-31) — Long Term Debt: 180550000.00
CARE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 180550000.00
CARE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 300550000.00
CARE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -127000000.00
CARE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2292000.00
CARE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 34945000.00
CARE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CARE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -42927000.00
CARE balance_sheet (annual, 2022-12-31) — Net Debt: 133681000.00
CARE income_statement (annual, 2022-12-31) — Net Income: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 50118000.00
CARE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 50118000.00
CARE income_statement (annual, 2022-12-31) — Net Interest Income: 139774000.00
CARE cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: 4840000.00
CARE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -31164000.00
CARE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 173550000.00
CARE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 173550000.00
CARE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -7388000.00
CARE balance_sheet (annual, 2022-12-31) — Net PPE: 72114000.00
CARE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5482000.00
CARE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 328627000.00
CARE income_statement (annual, 2022-12-31) — Normalized Income: 50118000.00
CARE income_statement (annual, 2022-12-31) — Occupancy And Equipment: 13527000.00
CARE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 70791000.00
CARE cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1047000.00
CARE income_statement (annual, 2022-12-31) — Operating Revenue: 158896000.00
CARE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 23956772.00
CARE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -85616000.00
CARE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2137000.00
CARE income_statement (annual, 2022-12-31) — Other Non Interest Expense: 19058000.00
CARE balance_sheet (annual, 2022-12-31) — Other Properties: 54872000.00
CARE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 836273000.00
CARE income_statement (annual, 2022-12-31) — Other Special Charges: -73000.00
CARE income_statement (annual, 2022-12-31) — Pretax Income: 61717000.00
CARE income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 5818000.00
CARE cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CARE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -135634000.00
CARE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5890000.00
CARE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 6063000.00
CARE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -127000000.00
CARE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -42927000.00
CARE balance_sheet (annual, 2022-12-31) — Retained Earnings: 285593000.00
CARE income_statement (annual, 2022-12-31) — Salaries And Wages: 52399000.00
CARE cash_flow (annual, 2022-12-31) — Sale Of Investment: 104470000.00
CARE cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 4840000.00
CARE cash_flow (annual, 2022-12-31) — Sale Of PPE: 408000.00
CARE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1434000.00
CARE income_statement (annual, 2022-12-31) — Selling General And Administration: 55848000.00
CARE balance_sheet (annual, 2022-12-31) — Share Issued: 23956772.00
CARE income_statement (annual, 2022-12-31) — Special Income Charges: 73000.00
CARE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1314000.00
CARE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 328627000.00
CARE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 328627000.00
CARE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (annual, 2022-12-31) — Tax Provision: 11599000.00
CARE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
CARE balance_sheet (annual, 2022-12-31) — Total Assets: 4204519000.00
CARE balance_sheet (annual, 2022-12-31) — Total Capitalization: 509177000.00
CARE balance_sheet (annual, 2022-12-31) — Total Debt: 180550000.00
CARE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 328627000.00
CARE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3875892000.00
CARE income_statement (annual, 2022-12-31) — Total Unusual Items: -359000.00
CARE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -359000.00
CARE cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CARE income_statement (annual, 2023-12-31) — +Total Revenue: 137713000.00
CARE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -41453000.00
CARE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 90642000.00
CARE cash_flow (annual, 2023-12-31) — Amortization Of Securities: 6354000.00
CARE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1117000.00
CARE income_statement (annual, 2023-12-31) — Basic Average Shares: 23240543.00
CARE income_statement (annual, 2023-12-31) — Basic EPS: 1.00
CARE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 46869000.00
CARE cash_flow (annual, 2023-12-31) — Capital Expenditure: -9798000.00
CARE balance_sheet (annual, 2023-12-31) — Capital Stock: 22957000.00
CARE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 54529000.00
CARE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 54529000.00
CARE balance_sheet (annual, 2023-12-31) — Cash Financial: 39676000.00
CARE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 267941000.00
CARE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -307011000.00
CARE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 46730000.00
CARE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -3849000.00
CARE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 3803000.00
CARE cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1381000.00
CARE cash_flow (annual, 2023-12-31) — Change In Working Capital: -1427000.00
CARE cash_flow (annual, 2023-12-31) — Changes In Cash: 7660000.00
CARE balance_sheet (annual, 2023-12-31) — Common Stock: 22957000.00
CARE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 351243000.00
CARE cash_flow (annual, 2023-12-31) — Common Stock Payments: -16416000.00
CARE cash_flow (annual, 2023-12-31) — Deferred Income Tax: 2469000.00
CARE cash_flow (annual, 2023-12-31) — Deferred Tax: 2469000.00
CARE cash_flow (annual, 2023-12-31) — Depreciation: 6248000.00
CARE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 6248000.00
CARE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 6248000.00
CARE income_statement (annual, 2023-12-31) — Diluted Average Shares: 23240543.00
CARE income_statement (annual, 2023-12-31) — Diluted EPS: 1.00
CARE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 23384000.00
CARE cash_flow (annual, 2023-12-31) — End Cash Position: 54529000.00
CARE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 267941000.00
CARE cash_flow (annual, 2023-12-31) — Free Cash Flow: 36932000.00
CARE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 1521000.00
CARE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CARE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CARE income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1521000.00
CARE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -71439000.00
CARE income_statement (annual, 2023-12-31) — General And Administrative Expense: 60760000.00
CARE balance_sheet (annual, 2023-12-31) — Gross PPE: 115160000.00
CARE cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 5693000.00
CARE income_statement (annual, 2023-12-31) — Insurance And Claims: 4904000.00
CARE income_statement (annual, 2023-12-31) — Interest Expense: 74110000.00
CARE income_statement (annual, 2023-12-31) — Interest Income: 194964000.00
CARE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 69116000.00
CARE balance_sheet (annual, 2023-12-31) — Invested Capital: 744643000.00
CARE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -307011000.00
CARE balance_sheet (annual, 2023-12-31) — Investments And Advances: 719643000.00
CARE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3441685000.00
CARE balance_sheet (annual, 2023-12-31) — Land And Improvements: 18826000.00
CARE balance_sheet (annual, 2023-12-31) — Leases: 1579000.00
CARE balance_sheet (annual, 2023-12-31) — Long Term Debt: 393400000.00
CARE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 393400000.00
CARE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3441685000.00
CARE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3228835000.00
CARE balance_sheet (annual, 2023-12-31) — Long Term Provisions: 3193000.00
CARE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 35772000.00
CARE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CARE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -16416000.00
CARE balance_sheet (annual, 2023-12-31) — Net Debt: 338871000.00
CARE income_statement (annual, 2023-12-31) — Net Income: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 23384000.00
CARE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 23384000.00
CARE income_statement (annual, 2023-12-31) — Net Interest Income: 120854000.00
CARE cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 6794000.00
CARE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 67286000.00
CARE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 212850000.00
CARE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 212850000.00
CARE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -11886000.00
CARE balance_sheet (annual, 2023-12-31) — Net PPE: 73707000.00
CARE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -9798000.00
CARE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 351243000.00
CARE income_statement (annual, 2023-12-31) — Normalized Income: 23384000.00
CARE balance_sheet (annual, 2023-12-31) — Notes Receivable: 59360000.00
CARE income_statement (annual, 2023-12-31) — Occupancy And Equipment: 14028000.00
CARE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 46730000.00
CARE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1631000.00
CARE income_statement (annual, 2023-12-31) — Operating Revenue: 137713000.00
CARE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 22956304.00
CARE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -71439000.00
CARE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 109000.00
CARE income_statement (annual, 2023-12-31) — Other Non Interest Expense: 19900000.00
CARE balance_sheet (annual, 2023-12-31) — Other Properties: 58983000.00
CARE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 719643000.00
CARE income_statement (annual, 2023-12-31) — Pretax Income: 28721000.00
CARE income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 6210000.00
CARE cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CARE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -24938000.00
CARE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -9798000.00
CARE balance_sheet (annual, 2023-12-31) — Receivables: 59360000.00
CARE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 6248000.00
CARE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3228835000.00
CARE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -16416000.00
CARE balance_sheet (annual, 2023-12-31) — Retained Earnings: 309083000.00
CARE income_statement (annual, 2023-12-31) — Salaries And Wages: 55856000.00
CARE cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CARE cash_flow (annual, 2023-12-31) — Sale Of Investment: 92224000.00
CARE cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 6794000.00
CARE cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CARE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1693000.00
CARE income_statement (annual, 2023-12-31) — Selling General And Administration: 62453000.00
CARE balance_sheet (annual, 2023-12-31) — Share Issued: 22956304.00
CARE income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CARE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1561000.00
CARE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 351243000.00
CARE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 351243000.00
CARE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (annual, 2023-12-31) — Tax Provision: 5337000.00
CARE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
CARE balance_sheet (annual, 2023-12-31) — Total Assets: 4512539000.00
CARE balance_sheet (annual, 2023-12-31) — Total Capitalization: 744643000.00
CARE balance_sheet (annual, 2023-12-31) — Total Debt: 393400000.00
CARE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 351243000.00
CARE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4161296000.00
CARE income_statement (annual, 2023-12-31) — Total Unusual Items: -1100000.00
CARE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1100000.00
CARE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CARE cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CARE cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
CARE cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
CARE balance_sheet (quarterly, 2024-09-30) — Notes Receivable: 62307000.00
CARE income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 58000.00
CARE balance_sheet (quarterly, 2024-09-30) — Receivables: 62307000.00
CARE cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
CARE income_statement (annual, 2024-12-31) — +Total Revenue: 132402000.00
CARE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -47522000.00
CARE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -47522000.00
CARE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 92159000.00
CARE cash_flow (annual, 2024-12-31) — Amortization Of Securities: 3592000.00
CARE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 10041000.00
CARE income_statement (annual, 2024-12-31) — Basic Average Shares: 23240543.00
CARE income_statement (annual, 2024-12-31) — Basic EPS: 1.06
CARE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 54529000.00
CARE cash_flow (annual, 2024-12-31) — Capital Expenditure: -8133000.00
CARE balance_sheet (annual, 2024-12-31) — Capital Stock: 23069000.00
CARE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 131171000.00
CARE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 137658000.00
CARE balance_sheet (annual, 2024-12-31) — Cash Financial: 39608000.00
CARE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 108106000.00
CARE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -68402000.00
CARE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 36938000.00
CARE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1614000.00
CARE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 1687000.00
CARE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1473000.00
CARE cash_flow (annual, 2024-12-31) — Change In Working Capital: 1828000.00
CARE cash_flow (annual, 2024-12-31) — Changes In Cash: 76642000.00
CARE balance_sheet (annual, 2024-12-31) — Common Stock: 23069000.00
CARE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 384313000.00
CARE cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CARE cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
CARE cash_flow (annual, 2024-12-31) — Deferred Income Tax: 3206000.00
CARE cash_flow (annual, 2024-12-31) — Deferred Tax: 3206000.00
CARE cash_flow (annual, 2024-12-31) — Depreciation: 7055000.00
CARE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 7055000.00
CARE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 7055000.00
CARE income_statement (annual, 2024-12-31) — Diluted Average Shares: 23240543.00
CARE income_statement (annual, 2024-12-31) — Diluted EPS: 1.06
CARE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 24523000.00
CARE cash_flow (annual, 2024-12-31) — End Cash Position: 131171000.00
CARE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 108106000.00
CARE cash_flow (annual, 2024-12-31) — Free Cash Flow: 28805000.00
CARE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -68000.00
CARE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 68000.00
CARE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -64521000.00
CARE income_statement (annual, 2024-12-31) — General And Administrative Expense: 64108000.00
CARE balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
CARE balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
CARE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
CARE balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
CARE balance_sheet (annual, 2024-12-31) — Gross PPE: 121851000.00
CARE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 121851000.00
CARE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 303000.00
CARE cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 21000.00
CARE income_statement (annual, 2024-12-31) — Insurance And Claims: 6200000.00
CARE income_statement (annual, 2024-12-31) — Interest Expense: 107272000.00
CARE income_statement (annual, 2024-12-31) — Interest Income: 220717000.00
CARE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 106342000.00
CARE balance_sheet (annual, 2024-12-31) — Invested Capital: 454313000.00
CARE balance_sheet (quarterly, 2024-12-31) — Invested Capital: 454313000.00
CARE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -68402000.00
CARE balance_sheet (annual, 2024-12-31) — Investments And Advances: 728441000.00
CARE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1870000000.00
CARE balance_sheet (annual, 2024-12-31) — Land And Improvements: 18610000.00
CARE balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 18610000.00
CARE balance_sheet (annual, 2024-12-31) — Leases: 3023000.00
CARE balance_sheet (quarterly, 2024-12-31) — Leases: 3023000.00
CARE balance_sheet (annual, 2024-12-31) — Long Term Debt: 70000000.00
CARE balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 70000000.00
CARE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 70000000.00
CARE balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 70000000.00
CARE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1870000000.00
CARE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2193400000.00
CARE balance_sheet (annual, 2024-12-31) — Long Term Provisions: 3186000.00
CARE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 40361000.00
CARE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 40361000.00
CARE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CARE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CARE cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CARE income_statement (annual, 2024-12-31) — Net Income: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 24523000.00
CARE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 24523000.00
CARE income_statement (annual, 2024-12-31) — Net Interest Income: 113445000.00
CARE cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 4199000.00
CARE cash_flow (quarterly, 2024-12-31) — Net Investment Properties Purchase And Sale: 1215000.00
CARE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 56281000.00
CARE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -323400000.00
CARE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -323400000.00
CARE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 15139000.00
CARE balance_sheet (annual, 2024-12-31) — Net PPE: 74329000.00
CARE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8133000.00
CARE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 384313000.00
CARE income_statement (annual, 2024-12-31) — Normalized Income: 24523000.00
CARE balance_sheet (annual, 2024-12-31) — Notes Receivable: 63450000.00
CARE balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 63450000.00
CARE income_statement (annual, 2024-12-31) — Occupancy And Equipment: 15608000.00
CARE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 36938000.00
CARE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -69000.00
CARE income_statement (annual, 2024-12-31) — Operating Revenue: 132402000.00
CARE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 23069175.00
CARE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -64521000.00
CARE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 138000.00
CARE income_statement (annual, 2024-12-31) — Other Non Interest Expense: 18648000.00
CARE balance_sheet (annual, 2024-12-31) — Other Properties: 59857000.00
CARE balance_sheet (quarterly, 2024-12-31) — Other Properties: 59857000.00
CARE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 718400000.00
CARE income_statement (annual, 2024-12-31) — Pretax Income: 30869000.00
CARE income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 5675000.00
CARE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -25126000.00
CARE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -8133000.00
CARE balance_sheet (annual, 2024-12-31) — Receivables: 63450000.00
CARE balance_sheet (quarterly, 2024-12-31) — Receivables: 63450000.00
CARE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 7055000.00
CARE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2193400000.00
CARE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CARE cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CARE balance_sheet (annual, 2024-12-31) — Retained Earnings: 333606000.00
CARE income_statement (annual, 2024-12-31) — Salaries And Wages: 57908000.00
CARE cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CARE cash_flow (annual, 2024-12-31) — Sale Of Investment: 81407000.00
CARE cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 4199000.00
CARE cash_flow (quarterly, 2024-12-31) — Sale Of Investment Properties: 1215000.00
CARE cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CARE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 2540000.00
CARE income_statement (annual, 2024-12-31) — Selling General And Administration: 66648000.00
CARE balance_sheet (annual, 2024-12-31) — Share Issued: 23069175.00
CARE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1752000.00
CARE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 384313000.00
CARE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 384313000.00
CARE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (annual, 2024-12-31) — Tax Provision: 6346000.00
CARE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CARE balance_sheet (annual, 2024-12-31) — Total Assets: 4659189000.00
CARE balance_sheet (annual, 2024-12-31) — Total Capitalization: 454313000.00
CARE balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 454313000.00
CARE balance_sheet (annual, 2024-12-31) — Total Debt: 70000000.00
CARE balance_sheet (quarterly, 2024-12-31) — Total Debt: 70000000.00
CARE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 384313000.00
CARE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4274876000.00
CARE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -41000.00
CARE income_statement (quarterly, 2025-03-31) — +Total Revenue: 36047000.00
CARE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 92418000.00
CARE cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 875000.00
CARE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 10178000.00
CARE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 22873800.00
CARE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.39
CARE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 131171000.00
CARE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1523000.00
CARE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 23162000.00
CARE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 88999000.00
CARE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 88999000.00
CARE balance_sheet (quarterly, 2025-03-31) — Cash Financial: 42509000.00
CARE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 32506000.00
CARE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -81054000.00
CARE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 6376000.00
CARE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1868000.00
CARE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -4955000.00
CARE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -341000.00
CARE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3428000.00
CARE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -42172000.00
CARE balance_sheet (quarterly, 2025-03-31) — Common Stock: 23162000.00
CARE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 401766000.00
CARE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 1283000.00
CARE cash_flow (quarterly, 2025-03-31) — Deferred Tax: 1283000.00
CARE cash_flow (quarterly, 2025-03-31) — Depreciation: 1911000.00
CARE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1911000.00
CARE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1911000.00
CARE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 22873800.00
CARE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.39
CARE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 8860000.00
CARE cash_flow (quarterly, 2025-03-31) — End Cash Position: 88999000.00
CARE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 32506000.00
CARE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 4853000.00
CARE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
CARE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 0.00
CARE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -56373000.00
CARE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15087000.00
CARE cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 15000.00
CARE income_statement (quarterly, 2025-03-31) — Insurance And Claims: 1430000.00
CARE income_statement (quarterly, 2025-03-31) — Interest Expense: 25869000.00
CARE income_statement (quarterly, 2025-03-31) — Interest Income: 55895000.00
CARE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 27354000.00
CARE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 456766000.00
CARE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -81054000.00
CARE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 691795000.00
CARE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 25000000.00
CARE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 55000000.00
CARE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 55000000.00
CARE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 25000000.00
CARE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -40000000.00
CARE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3072000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income: 8953000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 8860000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 8953000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8953000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8953000.00
CARE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 8953000.00
CARE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 8953000.00
CARE income_statement (quarterly, 2025-03-31) — Net Interest Income: 30026000.00
CARE cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
CARE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -17482000.00
CARE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -15000000.00
CARE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -15000000.00
CARE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1299000.00
CARE balance_sheet (quarterly, 2025-03-31) — Net PPE: 73944000.00
CARE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1523000.00
CARE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 401766000.00
CARE income_statement (quarterly, 2025-03-31) — Normalized Income: 8953000.00
CARE balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 63773000.00
CARE income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 4472000.00
CARE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 6376000.00
CARE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 145000.00
CARE income_statement (quarterly, 2025-03-31) — Operating Revenue: 36047000.00
CARE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 23161993.00
CARE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -56373000.00
CARE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1568000.00
CARE income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 5350000.00
CARE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 681617000.00
CARE income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 93000.00
CARE income_statement (quarterly, 2025-03-31) — Pretax Income: 11136000.00
CARE income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 1230000.00
CARE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -33681000.00
CARE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1523000.00
CARE balance_sheet (quarterly, 2025-03-31) — Receivables: 63773000.00
CARE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1911000.00
CARE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -40000000.00
CARE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 342559000.00
CARE income_statement (quarterly, 2025-03-31) — Salaries And Wages: 13657000.00
CARE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 16199000.00
CARE cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
CARE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 911000.00
CARE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15998000.00
CARE balance_sheet (quarterly, 2025-03-31) — Share Issued: 23161993.00
CARE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 481000.00
CARE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 401766000.00
CARE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 401766000.00
CARE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (quarterly, 2025-03-31) — Tax Provision: 2183000.00
CARE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
CARE balance_sheet (quarterly, 2025-03-31) — Total Assets: 4700287000.00
CARE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 456766000.00
CARE balance_sheet (quarterly, 2025-03-31) — Total Debt: 55000000.00
CARE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 401766000.00
CARE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4298521000.00
CARE cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -137000.00
CARE income_statement (quarterly, 2025-06-30) — +Total Revenue: 36276000.00
CARE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 84146000.00
CARE cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 832000.00
CARE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 10200000.00
CARE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 22805881.00
CARE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.37
CARE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 88999000.00
CARE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1917000.00
CARE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 22670000.00
CARE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 99905000.00
CARE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 99905000.00
CARE balance_sheet (quarterly, 2025-06-30) — Cash Financial: 48015000.00
CARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 14747000.00
CARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -13440000.00
CARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 9599000.00
CARE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1134000.00
CARE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 1239000.00
CARE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -357000.00
CARE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -252000.00
CARE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 10906000.00
CARE balance_sheet (quarterly, 2025-06-30) — Common Stock: 22670000.00
CARE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 405635000.00
CARE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 670000.00
CARE cash_flow (quarterly, 2025-06-30) — Deferred Tax: 670000.00
CARE cash_flow (quarterly, 2025-06-30) — Depreciation: 1939000.00
CARE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1939000.00
CARE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1939000.00
CARE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 22805881.00
CARE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.37
CARE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 8413000.00
CARE cash_flow (quarterly, 2025-06-30) — End Cash Position: 99905000.00
CARE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 14747000.00
CARE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 7682000.00
CARE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CARE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 0.00
CARE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -52250000.00
CARE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15825000.00
CARE balance_sheet (quarterly, 2025-06-30) — Goodwill: 1193000.00
CARE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2266000.00
CARE cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1479000.00
CARE income_statement (quarterly, 2025-06-30) — Insurance And Claims: 1436000.00
CARE income_statement (quarterly, 2025-06-30) — Interest Expense: 25388000.00
CARE income_statement (quarterly, 2025-06-30) — Interest Income: 57607000.00
CARE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 25446000.00
CARE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 519135000.00
CARE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -13440000.00
CARE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 701404000.00
CARE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 220000000.00
CARE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 113500000.00
CARE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 113500000.00
CARE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 220000000.00
CARE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -161500000.00
CARE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2737000.00
CARE balance_sheet (quarterly, 2025-06-30) — Net Debt: 13595000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income: 8510000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 8413000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 8510000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8510000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8510000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 8510000.00
CARE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 8510000.00
CARE income_statement (quarterly, 2025-06-30) — Net Interest Income: 32219000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: 473000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -5390000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 58500000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 58500000.00
CARE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -388000.00
CARE balance_sheet (quarterly, 2025-06-30) — Net PPE: 72105000.00
CARE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1917000.00
CARE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 403369000.00
CARE income_statement (quarterly, 2025-06-30) — Normalized Income: 8510000.00
CARE balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 64008000.00
CARE income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 4230000.00
CARE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 9599000.00
CARE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 11000.00
CARE income_statement (quarterly, 2025-06-30) — Operating Revenue: 36276000.00
CARE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 22669834.00
CARE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -52250000.00
CARE income_statement (quarterly, 2025-06-30) — Other Gand A: 307000.00
CARE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1073000.00
CARE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 47000.00
CARE income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 5629000.00
CARE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 691204000.00
CARE income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 97000.00
CARE income_statement (quarterly, 2025-06-30) — Pretax Income: 10628000.00
CARE income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 1921000.00
CARE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -19636000.00
CARE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1917000.00
CARE balance_sheet (quarterly, 2025-06-30) — Receivables: 64008000.00
CARE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1939000.00
CARE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -161500000.00
CARE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 351069000.00
CARE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 14082000.00
CARE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 14246000.00
CARE cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 473000.00
CARE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 708000.00
CARE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 16533000.00
CARE balance_sheet (quarterly, 2025-06-30) — Share Issued: 22669834.00
CARE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 529000.00
CARE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 405635000.00
CARE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 403369000.00
CARE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (quarterly, 2025-06-30) — Tax Provision: 2118000.00
CARE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
CARE balance_sheet (quarterly, 2025-06-30) — Total Assets: 4784091000.00
CARE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 519135000.00
CARE balance_sheet (quarterly, 2025-06-30) — Total Debt: 113500000.00
CARE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 405635000.00
CARE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4378456000.00
CARE cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -22000.00
CARE income_statement (quarterly, 2025-09-30) — +Total Revenue: 38130000.00
CARE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 79997000.00
CARE cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 784000.00
CARE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 10269000.00
CARE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 22294228.00
CARE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.24
CARE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 99905000.00
CARE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1539000.00
CARE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 22406000.00
CARE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 106948000.00
CARE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 106948000.00
CARE balance_sheet (quarterly, 2025-09-30) — Cash Financial: 42557000.00
CARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 45204000.00
CARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -49976000.00
CARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 11815000.00
CARE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 1827000.00
CARE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -813000.00
CARE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -357000.00
CARE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 657000.00
CARE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7043000.00